China SXT Pharmaceuticals, Inc.
General ticker "SXTC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.9M (TTM average)
China SXT Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -17.2%.
Estimated limits based on current volatility of 2.4%: low 1.40$, high 1.47$
Factors to consider:
- Total employees count: 96 as of 2019
Short-term SXTC quotes
Long-term SXTC plot
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $1.97MM | $1.93MM | $1.74MM |
| Operating Expenses | $7.58MM | $4.44MM | $4.42MM |
| Operating Income | $-5.61MM | $-2.52MM | $-2.68MM |
| Non-Operating Income | $-0.33MM | $-0.58MM | $-0.62MM |
| Interest Expense | $0.48MM | $0.54MM | $0.65MM |
| R&D Expense | $0.00MM | $0.18MM | $0.19MM |
| Income(Loss) | $-5.93MM | $-3.10MM | $-3.30MM |
| Profit(Loss)* | $-5.93MM | $-3.10MM | $-3.30MM |
| Stockholders Equity | $14.69MM | $13.93MM | $15.44MM |
| Inventory | $0.53MM | $0.81MM | $0.83MM |
| Assets | $29.55MM | $23.13MM | $21.66MM |
| Operating Cash Flow | $-0.08MM | $-1.93MM | $-2.35MM |
| Capital expenditure | $0.07MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $0.03MM | $0.06MM |
| Financing Cash Flow | $2.94MM | $-2.62MM | $8.40MM |
| Earnings Per Share** | $-22.23 | $-3.57 | $-8.18 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.